Education and imaging. Gastrointestinal: Improvement of granuloma annulare with anti-tumour necrosis factor alpha therapy for Crohn's disease

J Gastroenterol Hepatol. 2010 Jan;25(1):215. doi: 10.1111/j.1440-1746.2009.06098.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adalimumab
  • Anti-Inflammatory Agents / administration & dosage*
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Crohn Disease / complications
  • Crohn Disease / drug therapy*
  • Crohn Disease / immunology
  • Crohn Disease / pathology
  • Female
  • Gastrointestinal Agents / administration & dosage*
  • Granuloma Annulare / complications
  • Granuloma Annulare / drug therapy*
  • Granuloma Annulare / immunology
  • Granuloma Annulare / pathology
  • Humans
  • Infliximab
  • Middle Aged
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab